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Pemeabilisecl, dimethyl sulphoxide-differentiated HL-60 human myelomonocytic leukemia cells accumulate 
4sCa in an ATPdependent manner. The 45Ca is taken up by a pool thought to be a component ofthe endop 
lasmic reticulum. Inositol trisphosphate induced a rapid release of Ca from this pool, suggesting that this 
molecule which is formed in these cells in response to f-Met-Leu-Phe may play a role in agonist-induced 
Ca metabolism. 
HL-60 cell f-Met-Leu-Phe calcium Inositol1,4,5&sphosphate Intracellular messenger 
1. INTRODUCTION 
When HL-60 human myelomonocytic leukemia 
ceils are treated with dimethyl sulphoxide (DPSO) 
they differentiate into granulocytes which perform 
many of the functions of neutrophils [1,2]. They 
are able to show chemotaxis and to degranulate in 
response to f-Met-Leu-Phe (FMLP) [1,2], effects 
which in the neutrophil are mediated by a rise in 
intracellular calcium ([Ca’+]i) [3-51. 
A recent study of these DMSO-differentiated 
HL-60 cells, in which they were proposed as a con- 
venient model for the neutrophil, showed that one 
of the first actions of FMLP was the phospho- 
lipase C-mediated breakdown of phosphatidylino- 
Abbreviations: DMSO, dimethyl sulphoxide; FMLP, 
formylmethionylleucylphenylaIanine; PI(4,5)Pz, phos- 
phatidylinositol4,5bisphosphate; IPa, inositol trisphos- 
phate; (1,4,5)iP3, inositol 1,4,Qrisphosphate; ER, en- 
doplasmic reticulum; (4,5)IPz, inositol4$bisphosphate 
sitol4,5bisphosphate [PI(4,5)Pz] to form inositol 
trisphosphate (IPs) [2]. 
(1,4,5)IP~, the expected breakdown product of 
phosphodiesteratic attack of PI(4,5)P2, has re- 
cently been shown to induce Ca release from ATP- 
dependent non-mitochondrial vesicular pool of 
certain permeable cell preparations [6-81 and from 
liver [9] and insulinoma microsomes [18]. In light 
of these findings it has been suggested that 
(1,4,5)IPs may be a messenger which signals intra- 
cellular Ca release after Ca-mobilising hormone 
stimulation of these tissues. 
Here, we have shown that (1,4,5)IPs also causes 
Ca release from permeable DMSO-differentiated 
HL-60 cells. The Ca is released from an ATP- 
dependent non-mitochondrial pool likely to be a 
component of the ER. These findings support the 
suggestion that (1,4,5)IPs may also be the mes- 
senger which causes intracellular Ca-mobilisation 
in neutrophils [2] after activation of their plasma- 
membrane receptors with FMLP and other Ca- 
mobilising agonists. 
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2. METHODS 
2.1. HL-60 cell culture 
HL-60 myelomonocytic leukemia cells were cul- 
tured as described previously [2]. The cells were 
differentiated into granulocytes by culturing for 
6-7 days in the presence of DMSO (1.3%, v/v) 
and dexamethasone (1 FM). 
2.2. Preparation of permeable DMSO-differen tiated 
HL-60 cells 
The ~fferentiated cells were centrifuged and re- 
suspended in a cytasolic-type medium [IO] which 
had the following composition (mM): NaCl, 20.0; 
KCl, 100; MgS04,5.0; NaH2PO4,0.96; NaHC03, 
25; EGTA, 1 .O and 2% albumin at pH 7.2 and 
37°C. The cells were then exposed to saponin 
(lSOag/ml) for a period of S-10 min until more 
than 99% of the cells became permeable to trypan 
blue. The cells were then washed and resuspended 
in a medium of the same com~si~on but without 
saponin at a cell density of -2 x 10’ cells/ml. At 
this stage the medium was usually also supple- 
mented with antimycin (10pM) to prevent sub- 
strate oxidation, and an ATP-regenerating system 
consisting of creatine phosphate (5 mM) and 
creatine phosphokinase (5U/ml) to keep the level 
of any added ATP constant (for further details, see 
figure legends for each experiment). Ca-EGTA 
buffers were used to set free Ca concentrations a  
described previously HO]. 
This treatment causes the plasma membranes of
cells to become permeable to small molecules and 
ions while leaving the membranes ofthe intracellu- 
lar organelles intact [iOf. The advantage of such a 
permeable cell preparation isthat the composition 
of the medium surrounding the intracellular orga- 
nelles can be controlled in what is a semi-intact 
system. 
2.3. Measurement of 45Ca contents of saponin- 
treated, DUSt3-dgferentiated HL-60 cells 
Cells were incubated with 1 &i/ml 45Ca t a cell 
density of -1 mg/ml cellular protein for the times 
indicated in in~vidu~ experiments. Contents of 
45Ca were determined by diluting lOO-,ul ahquots of 
cell suspension i  10ml ice-cold isotonic sucrose 
(310 mM) containing EGTA (4mM) and tracer 
amounts (0.5,,&i/ml) of [‘HI moose for deter- 
mination of trapped volumes. The samples were 
194 
rapidly filtered through GF/C filters and washed 
with 10 ml of ice-cold isotonic sucrose. The radio- 
activity on the filters was then determined by liquid 
scintillation spectrophotometry. 
2.4. Preparation of inositol phosphates 
(1,4,5)IPs and inositol 4,5-bisphosphate [1(4,5)P~] 
were prepared from brain inositol fractions as 
described originally [ 11,12] with modifications as 
in [13]. 
2.4. Materials 
Radioactive materials were obtained from New 
England Nuclear. All other compounds were ob- 
tained from Sigma. 
3. RESULTS AND DISCUSSION 
To examine the hypothesis that (1,4,5)IP3 might 
be involved in the mobilisation of intracellular Ca 
in neutro~h~s, purified (1,4,5)IPs was applied to 
saponin-treated DMSO-differentiated HL-60 cells. 
In the experiments in fig.1 these permeable cells 
were incubated in the cytosolic-type medium 
0 t 1 I 1 t I 
0 to 20 30 40 50 60 
TIME fmin) 
Fig.1. Uptake of 45Ca by saponin-treated DMSO-dif- 
ferentiated HL-40 cells. At time zero 45Ca was added to 
a suspension of cells incubated in the cytosolic-type 
medium described in section 2 containing antimycin, the 
ATP-regenerating system and with [Ca”] set at 1801&f. 
At 10 min ATP was added and there was a rapid uptake 
of 45Ca by the cells. l , control; 0, 0.5 mM DNP and 
1OrM oligomycin present from time zero. The data were 
averaged and the bars indicate SE. n = 3. 
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described previously, with Ca2’ buffered to 
180nM, plus tracer amounts of 45Ca. This [Ca2+] 
was chosen because it has been shown in neutro- 
phils [5] and other tissues [10,14] that [Ca”]i, in 
intact unstimulated cells, lies between 100 and 
200 r&I. On addition of ATP (1.5 mM) the per- 
meable cells accumulated 45Ca to a level of about 
0.9 f 0.16 mnol/mg protein (n = 3) from a basal 
pre-ATP value of about 0.2 nmol/mg protein. This 
uptake was not affected if the mitochondrial in- 
hibitors 2,bdinitrophenol (DNP) and oligomycin 
were included in the medium. This indicates that at 
this [Ca2’] the mitochondria of the permeable cells 
were unable to accumulate Ca and that the 45Ca 
was probably being taken up into the ER. This is 
in agreement with results obtained in other per- 
meable cell preparations where it has been found 
that only the ER can take up Ca when the [Ca2+] 
in the medium is set around 2OOnM (i.e., resting 
[Ca2’]i), and where it has also been found that the 
mitochondria can accumulate Ca only when the 
medium [Ca”] is greater than 1pM [10,15,16]. 
The effect of 5pM (1,4,5)IP3, a concentration 
which is maximally effective in permeable hepato- 
cytes [7,8,17] and other permeable cells [6,13], on 
the steady-state accumulation of 45Ca in the per- 
meable HL-60 cells, incubated as described in 
fig.1, is shown in fig.2. The (1,4,5)1& induced a 
POlLI 
0 IO 20 30 0 IO 20 30 0 IO 20 30 
TIME imln) 
Fig.2. The effect of (1,4,5)IPs and (4,5)IPz on the 45Ca 
content of saponin-treated DMSO-differentiated HL-60 
cells. The cells were incubated as described in fig.1. 
When a steady-state had been achieved after addition of 
ATP, (1,4,5)IPs (5tM), (4,5)IPz (5pM) or an equivalent 
volume of Hz0 were added. (1,4,5)IP, caused a rapid 
net efflux of 45Ca from the cells whereas (4,5)IP2 had no 
significant effect. Data were averaged and bars indicate 
SE. n = 7 for (1,4,5)IPs and Hz0 and 3 for (4,5)IPz. 
rapid efflux of about 0.3 nmol 45Ca/mg protein, or 
about 50% of the 45Ca taken up by the cells in 
response to ATP. The effect was maximal at 1 min, 
which was the first time point taken. Another ino- 
sit01 phosphate, (4,5)IPz, was tested to determine 
whether there were any structural requirements for 
Ca-releasing ability. (4,5)IPz, which was a much 
less potent Ca-releasing agonist in permeable hepa- 
tocytes [ 171 or Swiss 3T3 cells [ 131, did not cause 
any significant loss of 45Ca from the permeable 
DMSO-differentiated HL-60 cells when applied at 
5pM. 
In the experiments hown in fig.3 the permeable 
cells were incubated as in fig.l,2, with 180 nM 
Ca2+ in the medium but in the absence of added 
ATP and the ATP regenerating system. The cells 
bound 0.36 + 0.05 nmol 45Ca/mg protein in an 
ATP-independent manner, and this was not af- 
fected by the addition of (1,4,5)IP3 (5rM). The 
experiment shown in fig.3 indicates that the 
(1,4,5)IP3 did not cause the permeable cells to lose 
45Ca in a non-specific way by either binding or dis- 
placing the 45Ca. 
In conclusion, these results show that (1,4,5)IP~ 
can release 45Ca sequestered in an ATP-dependent 
( I, 4,5) IP, 
s : 0.1 I I 1 
24 26 28 30 
TIME (min) 
Fig.3. Effect of (1,4,5)IPs on the 45Ca associated with 
the permeabilised cells in the absence of ATP. The cells 
were incubated as described in fig. 1 but without the ATP 
regenerating system or any added ATP. (1,4,5)IPs 
(SCM) was without effect. Data were averaged and bars 
indicate SE. n = 3. 
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manner by a non-mitochondrial pool likely to be a 
component of the ER of permeable DMSO-dif- 
ferentiated HL-60 cells. The mechanism by which 
it does so seems fairly specific as it will not release 
Ca bound to thecells in an ATP-independent man- 
ner and another inositol phosphate, (4,5)IPt, does 
not release Ca when applied at the same concentra- 
tion as (1,4;5)IP3. This suggests that there is a 
receptor on which the (1,4,5)IP3 acts, which may, 
for example, increase the permeability of the ER to 
Ca (see 1171). It has been demonstrated in intact 
DMSO-differentiated HL-60 cells that FMLP- 
induced breakdown of PI(4,5)Pz, which is the 
source of the increased level of Ifs, is not mediated 
by the agonist-induced rise in [Ca2*]i [2]. As it has 
also been shown that IPs is formed rapidly enough 
in these cells after stimulation with FMLP so that 
its formation might preceed FMLP-induced de- 
granulation [2], and as intracellular Ca release is 
involved in the agonist-mediated rise in [Ca’+]i in 
neutrophils [J], the findings in this study suggest 
that as in other tissues [6-g], (1,4,5)IPs is the mes- 
senger which signals agonist-induced Ca mobilisa- 
tion in DMSO-differentiated HL-60 cells and by 
analogy in neutrophils. 
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